Clinical Trials List
Protocol NumberIHN01
2010-05-26 - 2012-12-31
Phase III
Terminated1
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 廖俊達 Division of Hematology & Oncology
- Tung-Chieh Chang Division of Radiation Therapy
- Shu-Hang Ag Division of Radiology
- 黃祥富 Division of Hematology & Oncology
- 鄭恩加 長庚大學醫事生物科技暨檢驗學系
- Sheng-Chieh Chan Division of Nuclear Medicine
- Cheng-Lung Hsu Division of Hematology & Oncology
- Ku-How Fang Division of Hematology & Oncology
- Tzu-Chen Yen Division of Nuclear Medicine
- 陳建誠 Division of Radiology
- 范綱行 Division of Radiation Therapy
- Chi-Ting Liau Division of Hematology & Oncology
- Kai-Ping Chang Division of Hematology & Oncology
- Li-Yu Lee Division of Others -
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
710 participants
